SAVIENT PHARMACEUTICALS

savient-pharmaceuticals-logo

Savient Pharmaceuticals is a specialty biopharmaceutical company focused on developing and commercializing KRYSTEXXAรขโ€žยข (pegloticase) for the treatment of chronic gout in adult patients refractory to conventional therapy. Savient has exclusively licensed worldwide rights to the technology related to KRYSTEXXA and its uses from Duke University ("Duke") and Mountain View Pharmaceuticals, Inc. ("MVP"). Duke developed the recombinant uricase enzyme and MVP developed the PEGylation technology us... ed in the manufacture of KRYSTEXXA. MVP and Duke have been granted U.S. and foreign patents disclosing and claiming the licensed technology and, in addition, Savient owns or co-owns U.S. and foreign patents and patent applications, which collectively form a broad portfolio of patents covering the composition, manufacture and methods of use and administration of KRYSTEXXA. Savient also manufactures and supplies Oxandrinร‚ยฎ (oxandrolone tablets, USP) CIII in the U.S.

#Website #More

SAVIENT PHARMACEUTICALS

Industry:
Biotechnology

Founded:
1980-01-01

Address:
East Brunswick, New Jersey, United States

Country:
United States

Website Url:
http://www.savientpharma.com

Total Employee:
51+

Status:
Closed

Contact:
732-418-9300

Technology used in webpage:
Google Apps For Business Pound Sterling


Official Site Inspections

http://www.savientpharma.com

  • Host name: ec2-54-165-131-183.compute-1.amazonaws.com
  • IP address: 54.165.131.183
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "Savient Pharmaceuticals"

Savient Pharmaceuticals - Wikipedia

Savient was incorporated in 1980 as Bio-Technology General Corp and changed its name in 2003. Savient later focused on commercializing pegloticase in the United States and completing the development and seeking regulatory approval in the European Union. The company also sold branded and generic versions of oxandrolone, a drug used to promote weight gain following invโ€ฆSee details»

SAVIENT PHARMACEUTICALS INC. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for SAVIENT PHARMACEUTICALS INC. of East Brunswick, NJ. Get the latest business insights from Dun โ€ฆSee details»

Savient Pharmaceuticals - Crunchbase Company Profile & Funding

May 23, 2019 Organization. Savient Pharmaceuticals . Connect to CRM . Save . Summary. People. Technology. Signals & News. About. Savient Pharmaceuticals is a specialty โ€ฆSee details»

Savient Pharmaceuticals Inc - Company Profile and News

Company profile page for Savient Pharmaceuticals Inc including stock price, company news, executives, board members, and contact informationSee details»

Savient Pharmaceuticals - PitchBook

Savient Pharmaceuticals General Information Description. Operator of a specialty biopharmaceutical company. The company and its subsidiaries are focused on developing and โ€ฆSee details»

About Savient Pharmaceuticals Inc (SVNT) - Investing.com

This page offers an in-depth profile of Savient Pharmaceuticals Inc, including a general overview of the company's business and key management.See details»

Savient Pharmaceuticals - Products, Competitors, Financials, โ€ฆ

Savient Pharmaceuticals is a specialty biopharmaceutical company focused on developing and commercializing KRYSTEXXA (pegloticase) for the treatment of chronic gout in adult patients โ€ฆSee details»

Overview, News & Similar companies - ZoomInfo.com

Mar 26, 2020 Who is Savient Pharmaceuticals. Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing and commercializing KRYSTEXXA® โ€ฆSee details»

Savient Pharmaceuticals Inc., Christopher G. Clement, - Walker's โ€ฆ

Business Information The group's principal activity is to develop, manufacture and market pharmaceutical products for unmet medical needs in both niche and larger market segments. โ€ฆSee details»

Savient Pharmaceuticals Inc. - BioCentury Company Profiles - BCIQ

Jan 20, 2014 Savient Pharmaceuticals Inc. - BioCentury Company Profiles for the biopharma industrySee details»

Salient - Crunchbase Company Profile & Funding

Organization. Salient . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number 45 42 80 63 โ€ฆSee details»

Salient Pharma Aps - Drug pipelines, Patents, Clinical trials - Synapse

Aug 26, 2024 Explore Salient Pharma Aps with its drug pipeline, therapeutic area, technology platform, .See details»

Savient Pharmaceuticals Announces CEO Appointment and โ€ฆ

Jul 10, 2012 Savient also announced a reorganization plan to better align its operations and budget which includes organizational changes designed to improve its operational efficiencies โ€ฆSee details»

Savient Pharmaceuticals Announces CEO Appointment and โ€ฆ

EAST BRUNSWICK, N.J., July 9, 2012 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today announced that the Company's Board of Directors has appointed Louis Ferrari, โ€ฆSee details»

Savient Pharmaceuticals files for Chapter 11 bankruptcy

Oct 15, 2013 U.S. biotech firm Savient Pharmaceuticals Inc filed for Chapter 11 bankruptcy protection in a Delaware court on Monday and said it has agreed to sell most of its assets to โ€ฆSee details»

Working at Savient Pharmaceuticals: 7 Reviews - Indeed

Jan 7, 2019 Reviews from Savient Pharmaceuticals employees about Savient Pharmaceuticals culture, salaries, benefits, work-life balance, management, job security, and more.See details»

Savient shares rise on Amgen takeover talk | Fierce Biotech

Oct 16, 2009 Shares of Savient Pharmaceuticals (SVNT) were up as much as 5 percent today on rumors that Amgen is interested in acquiring the company. Savient has submitted a BLA for โ€ฆSee details»

Savient Pharmaceuticals Receives Plan - Bloomberg Law News

May 21, 2014 Savient Pharmaceuticals Inc., a developer of a treatment for gout before its business was sold, got approval of a liquidating Chapter 11 plan, with U.S. Bankruptcy Judge โ€ฆSee details»

Salient Pharma ApS - LinkedIn

Salient Pharma ApS | 24 followers on LinkedIn. Salient was founded to develop new products based on patented Intellectual property originally developed by scientists at the University of โ€ฆSee details»

Salient

Salientgel kan hjælpe dig med, igen, at opleve glæden ved at spiseSee details»